VistaPharm Clobazam Oral Suspension 2.5 mg/mL Recall: Failed Stability Specifications
VistaPharm recalls certain Clobazam Oral Suspension 2.5 mg/mL bottles due to failed stability specifications. These products may not remain safe or effective over time.
Lower-risk recall
Failed Stability Specifications
Contact the company
What happened, in plain English
VistaPharm is recalling specific batches of Clobazam Oral Suspension 2.5 mg/mL (120 mL) bottles that failed stability tests. This means the medication could become unsafe or ineffective if stored for longer than the expiration date. Read more at govinfonow.com/recall/35396-vistapharm-clobazam-oral-suspension-2-5-mg-ml-recall-failed.
Source Summary by GovInfoNow · govinfonow.com/recall/35396-vistapharm-clobazam-oral-suspension-2-5-mg-ml-recall-failed · Updated August 18, 2026 · FDA enforcement record: FDA #D-0376-2022
Cite this page
“VistaPharm Clobazam Oral Suspension 2.5 mg/mL Recall: Failed Stability Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35396-vistapharm-clobazam-oral-suspension-2-5-mg-ml-recall-failed. Based on FDA recall #D-0376-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0376-2022%22&limit=1).
Why it’s dangerous
The medication failed stability specifications, meaning it may not remain safe or effective over time. This could lead to the product becoming unstable or ineffective if stored beyond the expiration date.
Who’s affected
People prescribed Clobazam by a doctor who received these specific batch numbers of the 120 mL bottles. Those with the medication nearing or past expiration dates are most at risk.
How to tell if you have this one
Check the product label for the batch numbers listed: 678900, 682000, 682400 (expiring 5/31/2022), 680600, 680800, 681000 (expiring 5/30/2022), 683200, 685200 (expiring 6/30/2022), and others listed in the recall notice.
- Brand
VistaPharm- Category
Drug
What to do — step by step
Check Product Label
Look for the batch numbers listed in the recall notice to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States including Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.9 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0376-2022 (January 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0376-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.